---
title: AmbioPharm vs Cytovance Biologics
slug_a: ambiopharm
slug_b: cytovance-biologics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/ambiopharm/cytovance-biologics
---

# AmbioPharm vs Cytovance Biologics

Side-by-side profile data from each company listing on this directory.

## AmbioPharm

- Profile: [/companies/ambiopharm](/companies/ambiopharm)

AmbioPharm — FDA-inspected peptide API manufacturer offering GMP custom synthesis, process development, analytical method validation, and vaccine peptide manufacturing from preclinical through commercial scale.

Services: 5. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (5).

### Services

- API Synthesis & Manufacturing
- Peptide Manufacturing
- Vaccine Manufacturing
- Process Development
- CMC Analytical Development

### Modalities

- Peptide
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)

## Cytovance Biologics

- Profile: [/companies/cytovance-biologics](/companies/cytovance-biologics)

Cytovance Biologics — U.S.-based CDMO offering end-to-end biomanufacturing services for antibodies, recombinant proteins, vaccines, and other biologics modalities, with dedicated microbial and mammalian facilities and in-house cell line development capabilities.

Services: 11. Modalities: 4. Indications: 2. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Biologics Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Microbial Fermentation
- Vaccine Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Peptide
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian
- Expression: Microbial